Insider Trading Summary for Esperion Therapeutics, Inc. (ESPR): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Jun-23 4:05 PM View:	15-Jun-23 Grant 0	Gotto Antonio M Jr Md D Phil Director		Esperion Therapeutics, Inc. - ESPR	22% 23.45K to 28.6K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:07 PM View:	15-Jun-23 Grant 0	Vitullo Nicole Director		Esperion Therapeutics, Inc. - ESPR	16% 31.77K to 36.92K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:06 PM View:	15-Jun-23 Grant 0	Shepard Jay Director		Esperion Therapeutics, Inc. - ESPR	22% 23.45K to 28.6K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:09 PM View:	15-Jun-23 Grant 0	Woody Tracy M Director		Esperion Therapeutics, Inc. - ESPR	18% 28.42K to 33.57K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:09 PM View:	15-Jun-23 Grant 0	Fuhrman Alan Director		Esperion Therapeutics, Inc. - ESPR	20% 25.25K to 30.4K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 10:00 PM View:	14-Mar-24 Grant 0	Koenig Sheldon L. President and CEO Director		Esperion Therapeutics, Inc. - ESPR	162% 292.82K to 766.82K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:34 PM View:	14-Mar-24 Grant 0	Foody Joanne M. Chief Medical Officer		Esperion Therapeutics, Inc. - ESPR	118% 127.06K to 277.06K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:08 PM View:	15-Jun-23 Grant 0	Fischer Seth H.Z. Director		Esperion Therapeutics, Inc. - ESPR	100% 0 to 5.15K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:33 PM View:	14-Mar-24 Grant 0	Looker Benjamin General Counsel		Esperion Therapeutics, Inc. - ESPR	120% 83.66K to 183.66K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:35 PM View:	14-Mar-24 Grant 0	Warren Eric Chief Commercial Officer		Esperion Therapeutics, Inc. - ESPR	140% 70.23K to 168.32K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:06 PM View:	15-Jun-23 Grant 0	Rocamboli Stephen Director		Esperion Therapeutics, Inc. - ESPR	100% 0 to 13.26K	0	0	--	--	Show Txns Hide Txns

16-Jun-23 4:08 PM View:	15-Jun-23 Grant 0	Carroll J Martin Director		Esperion Therapeutics, Inc. - ESPR	733% 5.0K to 41.65K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:32 PM View:	14-Mar-24 Grant 0	Halladay Benjamin Chief Financial Officer		Esperion Therapeutics, Inc. - ESPR	230% 73.94K to 243.94K	0	0	--	--	Show Txns Hide Txns

Esperion Therapeutics, Inc. (ESPR)

Last Year

26-Apr-23 -- 25-Apr-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--